News Column

ALLERGAN INC FILES (8-K) Disclosing Other Events, Financial Statements and Exhibits

June 2, 2014

Item 8.01. Other Events.

On June 2, 2014, Allergan, Inc. ("Allergan") issued a press release commenting on Valeant Pharmaceuticals International, Inc.'s and Pershing Square Capital Management, L.P.'s attempt to remove a majority of the members of the Board of Directors of Allergan in connection with the special meeting of Allergan stockholders they are seeking to have called for such purpose.

A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits. 99.1 Allergan, Inc. press release dated June 2, 2014


For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters